awmsg logo



ferric maltol (Feraccru®)


Reference No. 2631

Publication date:
31/01/2017


Appraisal information

ferric maltol (Feraccru®) 30 mg hard capsule


Company: Shield Therapeutics
BNF category: Nutrition and blood
NMG meeting date: 02/11/2016
AWMSG meeting date: 07/12/2016
   
   
Submission Type: Full Submission
Status: Not recommended
Advice No: 3816
Ministerial ratification: 30/01/2017

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Ferric maltol (Feraccru®) is not recommended for use within NHS Wales for the treatment of iron deficiency anaemia in adults with inflammatory bowel disease. The cost-effectiveness data presented in the submission were insufficient for AWMSG to recommend its use.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download